Xu Qing Bin

Xu Qing Bin


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2017 in Cardiovascular Therapeutics
Verified
Journal Article
Closed access
PDF file
RZRu Zhou
Ru Zhou
PMPing Ma
Ping Ma
AXAiqin Xiong
Aiqin Xiong
YXYehua Xu
Yehua Xu
YWYang Wang
Yang Wang
XBXu Qing Bin
Xu Qing Bin

16 March 2012 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Open access
PDF file
XLXiaobing Li
Xiaobing Li
XWXiao Wang
Xiao Wang
YGYafang Guo
Yafang Guo
NDNing Deng
Ning Deng
PZPing Zheng
Ping Zheng
GDGuidong Dai
Guidong Dai
Objectives: This study was designed to investigate the cardioprotective effects of matrine on regulation of endothelial nitric oxide synthase (eNOS) and asymmetric dimethylarginine (ADMA) in isoproterenol-induced acute myocardial ischaemic rats. Methods: Male Sprague–Dawley rats were pretreated with matrine (200, 100 and 50 mg/kg) orally for 10 days. Acute myocardial injury was induced in rats by subcutaneous injection of isoproterenol. Serum and haemodynamic parameters, histopathological variables and expression of protein levels were analysed. Key findings: Oral administration of matrine (200, 100 and 50 mg/kg) significantly attenuated isoproterenol-induced cardiac necrosis and left ventricular dysfunction. Matrine treatment restored impaired ventricular Akt and eNOS protein expression with concomitant increased phosphorylation of Akt (Ser473) and eNOS (Ser1177), and also restored glycogen synthase kinase 3β activity, as indicated by increased phosphorylation at Ser 9. Moreover, treatment with matrine had no effect on the isoproterenol-induced elevated protein arginine methyltransferase 1 protein expression, but could significantly normalize the reduced dimethylarginine dimethylaminohydrolase 2 expression and attenuate the increased serum level of ADMA. The expression of catechol-o-methyltransferase and monoamine oxidase did not differ among all groups (all P > 0.05). Conclusions: Our results suggested that matrine protects against isoproterenol-induced myocardial ischaemia via eNOS and ADMA pathway.

1 December 2016 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
RZRu Zhou
Ru Zhou
XBXu Qing Bin
Xu Qing Bin
YXYehua Xu
Yehua Xu
AXAiqin Xiong
Aiqin Xiong
YWYang Wang
Yang Wang
PMPing Ma
Ping Ma

1 November 2021 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YLYingjie Lv
Yingjie Lv
PMPengsheng Ma
Pengsheng Ma
JWJialing Wang
Jialing Wang
XBXu Qing Bin
Xu Qing Bin
JFJun Fan
Jun Fan
鲁周鲁 周
鲁 周

13 December 2023 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
YCYoulan Che
Youlan Che
TXTian Xia
Tian Xia
HLHui Liu
Hui Liu
CLCong Li
Cong Li
SLSiyun Liu
Siyun Liu
鲁周鲁 周
鲁 周

29 March 2024 in Medicine
Verified
Journal Article
Open access
SZShichang Mm Zhang
Shichang Mm Zhang
GHGuangxin Mm Hu
Guangxin Mm Hu
BZBotao Mm Zhang
Botao Mm Zhang
YLYinping Mm Li
Yinping Mm Li
BLBen Li
Ben Li
XBXu Qing Bin
Xu Qing Bin
Background: Coronary artery disease is a prevalent global cardiovascular ailment, with percutaneous coronary intervention (PCI) standing out as a crucial method for relieving symptoms and enhancing the quality of life in patients with coronary heart disease. However, the presence of concurrent chronic total occlusion (CTO) and bifurcation lesions within coronary arteries elevates the complexity and treatment risks, especially when the entry point of the CTO is ambiguous. Objective: This study aims to present an innovative approach for treating CTO complicated with bifurcation lesions, focusing on true cavity pathfinding assisted by a balloon. Methods: Two cases of CTO patients with concomitant bifurcation lesions are described. One case involves CTO of the left anterior descending artery) combined with anterior non-angle trigeminal lesions, while the other entails CTO of the posterior left artery combined with posterior angle trigeminal lesions. True lumen identification using a balloon and subsequent opening of the CTO blood vessel were performed in both cases. Results: In both cases, the true lumen was successfully located with the assistance of a balloon, leading to the successful opening of the CTO blood vessel. This approach not only simplified the procedure but also reduced procedural difficulty and associated risks of complications compared to traditional guide wire operations. Conclusion: The application of true cavity pathfinding assisted by a balloon offers a novel and effective strategy for managing CTO complicated with bifurcation lesions. The method simplifies the procedure, decreases procedural difficulty, and lowers the risk of complications associated with guide wire operations. However, further studies and long-term follow-up data are warranted to validate the reliability and long-term efficacy of this innovative approach.